Sarepta Therap

Forecast & Rating23 analysts currently cover Sarepta Therap, with about 30.4% giving a positive rating — meaning they expect the stock to rise. The average price target is $21.86, about 8.7% upside from the current price of $20.11. Price targets range from $5.00 to $38.00 — a wide spread, showing clear disagreement over just how much Sarepta Therap can rise. Historically, about 62.1% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Sarepta Therap's outlook. Data as of Sep 15, 2026; for reference only and not investment advice.